Teijin To Solidify Ortho Biz With Bone-Fixation Investment

Japan's Teijin is adding a family of bioresorbable, osteosynthetic bone-fixation devices to its modest but growing orthopedics portfolio.

Japanese tech group Teijin Ltd. is broadening its orthopedics portfolio by taking a majority stake in the bone-fixation business of Takiron.

Teijin will acquire an 86% share of the Osaka-based business, which sells the Osteotrans family of bioactive and resorbable osteosynthetic...

More from Orthopedics

More from Device Area